| Literature DB >> 21904529 |
Elisabeth Lambert1, Nora E Straznicky, Tye Dawood, Carolina Ika-Sari, Mariee Grima, Murray D Esler, Markus P Schlaich, Gavin W Lambert.
Abstract
Sympathetic activation in subjects with the metabolic syndrome (MS) plays a role in the pathogenesis of cardiovascular disease development. Diet-induced weight loss decreases sympathetic outflow. However the mechanisms that account for sympathetic inhibition are not known. We sought to provide a detailed description of the sympathetic response to diet by analyzing the firing behavior of single-unit sympathetic nerve fibers. Fourteen subjects (57 ± 2 years, nine men, five females) fulfilling ATP III criteria for the MS underwent a 3-month low calorie diet. Metabolic profile, hemodynamic parameters, and multi-unit and single-unit muscle sympathetic nerve activity (MSNA, microneurography) were assessed prior to and at the end of the diet. Patients' weight dropped from 96 ± 4 to 88 ± 3 kg (P < 0.001). This was associated with a decrease in systolic and diastolic blood pressure (-12 ± 3 and -5 ± 2 mmHg, P < 0.05), and in heart rate (-7 ± 2 bpm, P < 0.01) and an improvement in all metabolic parameters (fasting glucose: -0.302.1 ± 0.118 mmol/l, total cholesterol: -0.564 ± 0.164 mmol/l, triglycerides: -0.414 ± 0.137 mmol/l, P < 0.05). Multi-unit MSNA decreased from 68 ± 4 to 59 ± 5 bursts/100 heartbeats (P < 0.05). Single-unit MSNA indicated that the firing rate of individual vasoconstrictor fibers decreased from 59 ± 10 to 32 ± 4 spikes/100 heart beats (P < 0.05). The probability of firing decreased from 34 ± 5 to 23 ± 3% of heartbeats (P < 0.05), and the incidence of multiple firing decreased from 14 ± 4 to 6 ± 1% of heartbeats (P < 0.05). Cardiac and sympathetic baroreflex function were significantly improved (cardiac slope: 6.57 ± 0.69 to 9.57 ± 1.20 ms·mmHg(-1); sympathetic slope: -3.86 ± 0.34 to -5.05 ± 0.47 bursts/100 heartbeats·mmHg(-1), P < 0.05 for both). Hypocaloric diet decreased sympathetic activity and improved hemodynamic and metabolic parameters. The sympathoinhibition associated with weight loss involves marked changes, not only in the rate but also in the firing pattern of active vasoconstrictive fibers.Entities:
Keywords: autonomic function; diet; metabolic syndrome; sympathetic nervous system
Year: 2011 PMID: 21904529 PMCID: PMC3162210 DOI: 10.3389/fphys.2011.00052
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Figure 1Typical recording of single-unit and multi-unit muscle sympathetic nerve activity (MSNA). Single-unit MSNA was identified on the raw nerve and highlighted by the arrows. Superimposed spikes demonstrate consistent morphology.
Anthropometric, blood pressure, metabolic, and anxiety responses to diet.
| Before diet | After diet | |
|---|---|---|
| BMI (kg/m2) | 33.8 ± 1.1 | 30.9 ± 0.9*** |
| Weight (kg) | 96 ± 4 | 88 ± 3*** |
| Waist (cm) | 108 ± 3 | 100 ± 2*** |
| Hip (cm) | 115 ± 2 | 109 ± 2*** |
| Waist/hip | 0.94 ± 0.02 | 0.92 ± 0.02 |
| SBP (mmHg) | 136 ± 3 | 124 ± 5** |
| DBP (mmHg) | 77 ± 2 | 73 ± 3* |
| HR (bpm) | 68 ± 2 | 61 ± 2** |
| Total cholesterol (mmol/l) | 5.28 ± 0.44 | 4.71 ± 0.42** |
| LDL cholesterol (mmol/l) | 3.42 ± 0.37 | 3.03 ± 0.37* |
| HDL cholesterol (mmol/l) | 1.13 ± 0.07 | 1.16 ± 0.05 |
| Triglycerides (mmol/l) | 1.60 ± 0.24 | 1.19 ± 0.21** |
| Fasting glucose | 5.51 ± 0.15 | 5.21 ± 0.13* |
| Fasting insulin | 11.97 ± 1.61 | 10.39 ± 1.64* |
| HOMA | 3.01 ± 0.45 | 2.46 ± 0.41* |
| Leptin (ng/ml) | 13.79 ± 3.00 | 9.36 ± 2.3* |
| State anxiety | 38 ± 3 | 35 ± 3* |
| Trait anxiety | 36 ± 3 | 33 ± 2* |
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate. *.
Figure 2Multi-unit muscle sympathetic nerve activity (MSNA) measured as bursts per minute and bursts per 100 heartbeats at baseline (B) and 12 weeks following the diet. *P < 0.05, **P < 0.01.
Figure 3Single-unit muscle sympathetic nerve activity (MSNA) measured as firing rate, firing probability and probability of multiple firing at baseline (B) and 12 weeks following the diet. *P < 0.05.
Figure 4Cardiac (left panel) and sympathetic (right panel) baroreflex function gain measured at baseline (B) and 12 weeks following the diet. *P < 0.05, **P < 0.01.